Glycominds makes blood test breakthrough for MS (multiple sclerosis)
This article was originally published in Clinica
Executive Summary
Marking a first for multiple sclerosis (MS) diagnosis, researchers have used a blood test to predict whether patients will go on to develop the active form of the disease after experiencing their first neurological event.